# Aegerion Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aegerion-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Cambridge, US
- Website: www.novelion.com/about-novelion/aegerion-pharmaceuticals
- Total disclosed funding: $40M
- Latest round: Series B (Nov 15, 2007)
- Investors on record: 4

## About

Aegerion Pharmaceuticals, Inc. is engaged in the development and commercialization of innovative therapies for rare diseases, focusing on transforming the lives of patients with significant unmet medical needs.Aegerion Pharmaceuticals, Inc. specializes in creating treatments for rare diseases, established in 2005 in Cambridge, US. The company completed its IPO in October 2010, raising approximately USD 44.34 mn by selling 4.67 million shares at USD 9.50 each. It has also been involved in 7 deals throughout its history.The company provides innovative therapies aimed at treating rare diseases. Its product portfolio includes specialized medications that address significant health challenges for patients suffering from specific conditions. Aegerion focuses on delivering effective solutions that enhance the quality of life for individuals with rare medical needs across various regions.In 2015, Aegerion Pharmaceuticals, Inc. reported a revenue of USD 239.89 mn, with an EBITDA of USD -23.19 mn for the same year, reflecting the company's ongoing investment in product development and market expansion.Following its IPO in October 2010, Aegerion Pharmaceuticals, Inc. plans to leverage the raised USD 44.34 mn to further develop its product offerings and explore additional rare disease therapies. The company aims to expand its market presence beyond North America into Europe and Asia by 2025, focusing on enhancing its portfolio with new therapeutic options designed to meet the needs of patients in these regions.

## Funding rounds

- Series B, Nov 15, 2007, $18M — Advent International, Alta Partners, Index Ventures, MVM Partners
- Series A, Dec 29, 2005, $23M — Advent International, Alta Partners, Index Ventures, MVM Partners

## Investors

- Advent International (https://capitalatlas.ai/funds/advent-international) — Series A, Series B
- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series A, Series B
- Index Ventures (https://capitalatlas.ai/funds/index-ventures) — Series A, Series B
- MVM Partners (https://capitalatlas.ai/funds/mvm-partners) — Series A, Series B